"Among the most important innovations that will be available in the near future are anti-obesity pills and the triple agonist retatrutide." Professor Andrea Fabbri, a professor of Endocrinology at the University of Tor Vergata in Rome, explains: "Among the most important innovations that will be available in the near future are anti-obesity pills and the triple agonist retatrutide." #obesità #incretine #salute (translated)
Rivoluzione incretine, i farmaci anti-obesità ora diventano pillole. «Dosaggi saranno più facili da gestire»
www.ilmessaggero.it